Nerelimomab
Based on 1 publication(s) in Google Scholar
Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 162774-06-3
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
MedChemExpress(MCE)の使用を引用している文献 Nerelimomab
More
生物活性
Human IgG1 kappa
Human
TNF
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Baboon model of recurrent bacteremia (Challenged with E.coli)[1]
-
Dosage:7.5 mg/kg
-
Administration:i.v. infusion
-
Result:Improved organ function and attenuated cytokine and plasminogen activator inhibitor release.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-nd
ELISA, FACS, Functional assay
化学情報
-
CAS 番号 162774-06-3
-
SMILES
[Nerelimomab]
-
別名
BAYX1351
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Pharmaceuticals (Basel)
Nerelimomab Alleviates Capsaicin-Induced Acute Lung Injury by Inhibiting TNF Signaling and Apoptosis. [Abstract]2024 Dec 15;17(12):1694. PMID: 39770536
純度とドキュメンテーション
参考文献
[1]. Schlag G, et al. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock. 1994 Jul;2(1):10-8; discussion 19-22. [Content Brief]
[2]. Cohen J, et al. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med. 1996 Sep;24(9):1431-40. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)